Abstract. The present study investigated the effect of ryanodine receptors (RyRs) in the development and expression of morphineinduced conditioned place preference (CPP). Type 2 RyRs (RyRs2) in the nucleus accumbens (NAcc) significantly increased in morphineconditioned mice, whereas type 1, 2, and 3 RyRs in the frontal cortex and ventral tegmental area showed no changes. Intracerebroventricular pretreatment with dantrolene, a RyRs antagonist, during the conditioning phase of CPP, dosedependently inhibited morphineinduced CPP. The expression of morphineinduced CPP was abolished by dantrolene administration before the postconditioning test. These findings suggest that RyRs2 in the NAcc participate in the development and expres sion of morphineinduced CPP.
Short Communication
Animal models for drug dependence with morphine show dynamic behavioral response as a result of mole cular and/or neuronal changes in the brain by chronic morphine treatment (1) . A number of studies have demonstrated that changes in intracellular Ca 2+ concen tration play an essential role in regulating the develop ment of drug dependence (2, 3) . Ca 2+ entry through Ltype calcium channels is one of the essential factors for psychostimulantinduced place preference (3, 4) . Recently our report showed the involvement of the upregulation of Ltype calcium channels in the develop ment of morphineinduced place preference (5) . On the other hand, it has been reported that the activation of Cav1, a1subunit consisting of Ltype calcium channels, by membrane depolarization promotes ryanodine recep tors (RyRs)mediated Ca 2+ release from the endoplasmic reticulum through the process of Ca 2+ induced Ca 2+ release (ClCR) (6) . These data strongly suggest that increased Ca 2+ entry through upregulated Ltype calcium channels may modify RyR function subsequent to facili tation of CICR during continuous morphine administra tion producing morphine dependence.
RyRs have three isoforms, type 1 RyRs (RyRs1), type 2 RyRs (RyRs2), and type 3 RyRs (RyRs3); they are expressed in different levels at different sites of the central nervous system (7, 8) . A recent investigation reported that intracerebroventiricular injection of dantrolene, a RyR antagonist, blocked the development of methamphetamine and cocaineinduced place prefer ence (9, 10) , while there are little available data on the effect of dantrolene on morphineinduced place prefer ence in mice. The present study, therefore examined the role of RyRs in the development and expression of morphineinduced place preference using a conditioned place preference paradigm.
Male ddY mice (8weekold; Japan SLC, Inc., Hamamatsu) were housed in a room maintained at 22°C ± 1°C and 55% ± 0.5% in humidity with a 12h light/dark cycle for one week (light on 8:00 A.M. to 8:00 P.M.) before the following experiments. Food and water were available ad libitum. All animal experiments carried out in this study were approved by the Animal Research Committee of Kawasaki Medical School and conducted according to the "Guide for Care and Use of Laboratory Animals" of Kawasaki Medical School. Intracerebroventricular (i.c.v.) administration was carried according to the previous report (10) .
The conditioning place preference schedule consisted of three phases (preconditioning test, conditioning, and postconditioning test) (10) . A) The preconditioning test was performed as follows: mice were placed on the border of both compartments and then the time spent in each compartment during the 900s session was recorded automatically using an infrared beam sensor (BSCPPMS; BrainSienceldea, Co., Ltd., Osaka). The compartment in which the animal spent a longer time was defined as the preferred compartment and the other one was defined as the nonpreferred compartment. According to place preference the mice were divided into two groups, one group consisted of mice preferring the black compart ment and another preferring the white compartment. With such biased assignment, mice were conditioned in their nonpreferred compartment (drugpaired compart ment). B) Conditioning sessions: 3 days for morphine (Daiichi Sankyo Co., Ltd., Tokyo) or 3 days for saline were conducted once daily for 6 days. Immediately after s.c. injection of morphine, these animals were placed in the compartment opposite to their preferred one for 1 h. On an alternative day, these animals received saline and were placed in their preferred compartment for 1 h. As shown in Fig. 2A , dantrolene (1, 3, and 10 nmol/ mouse, i.c.v.; SigmaAldrich, St. Louis, MO, USA) was daily administered 30 min before the treatment with morphine (5 mg/kg) or saline during morphine condi tioning. C) The postconditioning test, which was identi cal to the preconditioning test, was performed on the day after the final conditioning session. The preference for the drugpaired place is expressed as the mean difference between the times spent during the post conditioning and preconditioning tests. For the experi ment examining the effect of dantrolane on the expres sion of the morphineinduced CPP, dantrolene (3 and 10 nmol/mouse, i.c.v.) was once administered 30 min before the postconditioning test (Fig. 2C) . Dantrolene was dissolved in 10% dimethylsulfoxide containing physiological saline and morphine hydrochloride was dissolved in physiological saline. Our previous study for checking dosedependency of morphine for morphine induced place preference (morphine: 1, 3, 5, and 10 mg/kg) showed that morphine increased place preference in a dosedependent manner and that the place preference by 5 mg/kg morphine was almost similar (not statistically significant) to that by 10 mg/kg morphine (5, 11). There fore, we used morphine at the dose of 5 mg/kg to examine morphineinduced place preference in this study.
In order to exclude the possibility that the procedure for conditioning place preference induces the change of RyR2 protein expression in the nucleus accumbens, we measured RyR2 protein expression after mice were housed in the home cage with injection of morphine and saline without examining conditioned place preference.
Mice were decapitated immediately after the post conditioning test, and several brain regions such as the frontal cortex, nucleus accumbens, and ventral tegmental area (VTA) including lower midbrain were quickly dissected on an icecold metal place.
The dissected brain tissues were homogenized in ice cold lysis buffer containing 10 mM TrisHCl (pH 7.5), 150 mM NaCl, 0.5 mM EDTA, 10 mM NaF, and 0.5% Triton X100 with a proteaseinhibitor cocktail (Roche Diagnostics, Indianapolis, USA) and centrifuged at 1,000 × g for 10 min. The resultant supernatant was further centrifuged at 100,000 × g for 60 min at 4°C. The final pellets (membranes fractions) were resuspended in icecold lysis buffer for western blotting. The brain samples (5 mg protein applied onto each lane) thus obtained were separated by 3% -8% Trisacetate gel (Invitrogen, Carlsbad, CA, USA; 150 V, 1h) and then transferred to nitrocellulose membranes with a wettype transblotter (90 V, 60 min). The membrane was incu bated overnight at 4°C with primary antibodies against RyR1 (mouse monoclonal antitype 1 RyRs 1:1000; SigmaAldrich, St. Louis, MO, USA), RyR2 (mouse mono clonal antitype 2 RyRs, 1:1000, SigmaAldrich), RyR3 (rabbit polyclonal antitype 3 RyRs, 1:1000; Mil lipore Bioscience Research Reagents, Temecula, CA, USA), and bactin (mouse monoclonal antibactin, 1:5000, sc47778; Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted in phosphatebuffered saline (PBS) containing 5% nonfat dried milk before the addi tional incubation with horseradish peroxidase-conju gated goat antirabbit or antimouse IgG diluted 1:5000 in PBS containing 5% nonfat dried milk for 2 h at room temperature. Protein bands were finally detected by chemiluminescence detection (ECL) reagents (GE Healthcare UK, Buckinghamshire, UK).
Samples for measuring RyR2 mRNA in the nucleus accumbens were prepared 24 h after one, two, and three conditioning sessions with morphine or saline and homogenized with TRIzol reagents (Invitrogen Co., Tokyo) according to the manufacturer's instruction. Total RNA (200 ng) was reacted with Prime Script reverse transcriptase (Takara, Kyoto) using One SYBR® PrimeScript® RTPCR kit II (Takara) and the 7500 realtime PCR system (Applied Biosystems, Foster City, CA, USA). The data were analyzed by the 7500 system SDS Software 1.3.1 (Applied Biosystems) using the standard curve method. The sequences of the primers for RyR2 and GAPDH were as follows: RyR2 forward primer: 5′-AGCTTGAAAGACACCGAGGA-3′ and re verse primer: 5′-TAGAGAGCCATCTCTGCCACCT-3′; 5′-AGGTCGGTGTGAACGGATTTG-3′ and reverse primer: 5′-TGTAGACCATGTAGTTGAGCTCA-3′. Fig. 1 . Changes in proteins of types 1, 2, and 3 RyRs in the membrane fraction of the mouse frontal cortex, nucleus accumbens, and ventral tegmental area following the morphineconditioning. FC, frontal cortex; NAcc, nucleus accumbens; VTA, ventral tegmental area; RyR1, type 1 RyRs; RyR2, type 2 RyRs; RyR3, type 3 RyRs. A) Mice were subcutaneously injected with saline (SAL) or morphine (MRP) three times every other day for 6 days. The membrane fraction for measuring RyRs were prepared 24 h after the last conditioning with morphine or SAL. Each column represents the mean ± S.E.M. of 4 mice. *P < 0.05 vs. VehSAL (Student's ttest) . B) Time course of RyR2 mRNA expression in the NAcc after morphine conditioning sessions. Samples for measuring RyR2 mRNA in the nucleus accumbens were prepared 24 h after the last conditioning (one, two, and three condition ing sessions) with MRP or SAL. Each column represents the mean ± S.E.M. of 6 mice. **P < 0.01, ***P < 0.001 vs. SAL (Student's ttest). C) Changes in protein levels of RyR2 in the membrane fractions of the NAcc of mice housed in their home cage with morphine treatment without measuring morphineinduced place preference. Mice were subcutaneously injected with saline or morphine (5 mg/kg) every other day over the period for 6 days. Membrane fractions used for measuring RyR2 protein were prepared 24 h after the last injection with morphine or saline. Each column represents the mean ± S.E.M. of 5 mice. Each column shows the mean intensity ratio to bactin or GAPDH.
Protein concentration in the samples was assayed by Micro BCA Protein Assay Kit (Thermo; Rockford, IL, USA).
Each of the data was represented as the mean ± S.E.M. Statistical analysis was carried out using Prism 5 (Graph Pad, San Diego, CA, USA). The statistical differences between saline and morphineconditioned groups in Fig. 1 were analyzed with Student's ttest. The statistical significance of difference between experimental groups in Fig. 2 was assessed with Tukey's multiple comparison test. A level of probability of 0.05 or less was considered to be statistically significant.
Western blot analysis showed that morphine condi tioning significantly increased RyR2 in the nucleus accumbens, although no changes in the expression of RyR1 and RyR3 in the nucleus accumbens were found (Fig. 1) . In contrast, the levels of these three types of RyRs showed no changes in the frontal cortex and VTA obtained from the morphineconditioned mice (Fig. 1) . Quantitative RTPCR analysis showed signifi cant increase of mRNA expression of RyR2 in the nucleus accumbens with one, two, and three morphine conditioning sessions (Fig. 1B) . In addition, RyR2 pro tein expression in mice by morphine treatment without the conditioning or postconditioning was not statistically different from that by saline treatment with out the conditioning or postconditioning changes in RyR2 protein expression (Fig. 1C) , indicating that the change of RyR2 protein expression observed in mice with morphineinduced place preference may be due being induced by the conditioning procedures.
The effect of dantrolene, a nonselective antagonist for RyRs, on the development of morphineinduced place preference was examined by intracerebroventricular (i.c.v.) injection of dantrolene. As shown in Fig. 2B , the increase of the morphineinduced place preference was suppressed by the pretreatment with dantrolene daily during the conditioning phase in a dosedependent manner. The effect of dantrolene on the expression of morphineinduced place preference was also examined by i.c.v. treatment with dantrolene before the post conditioning test. The pretreatment with dantrolene 30 min before the postconditioning test significantly suppressed Fig. 2 . Effects of dantrolene on morphineinduced place preference in mice. A) Schedule of the experiment for Fig. 2B . B) Effect of dantrolene on the development of morphineinduced place prefer ence. Dantrolene (1, 3, or 10 mol/mouse) was i.c.v. administered 30 min during the conditioning phase before subcutaneous treatment with saline (SAL) and morphine (MRP, 5 mg/kg). Mice were treated with SAL or morphine every other day over the period for 6 days. Each of the data represents the mean ± S.E.M. obtained from 8 animals. ***P < 0.001 (Tukey's multiple comparison test). C) Schedule of the experiment for Fig. 2D . D) Effect of dantrolene on the expression of morphineinduced place preference. Mice were treated with SAL or morphine every other day over the period for 6 days. Dantrolene (3 and 10 nmol/mouse, i.c.v.) were acutely admin istered 30 min before the postconditioning test. Each of the data represents the mean ± S.E.M. obtained from 6 animals. ***P < 0.001 (Tukey's multiple comparison test). the expression of morphineinduced place preference (Fig. 2D) . In the present study we used dantrolene as a nonselective antagonist of RyR2, which is not commercially available at present. The dantrolene bind ing site is located in the Leu 590 -Cys 609 region of the proposed RyR1 domain. The amino acid sequence of Leu 590 -Cys 609 region is exactly identical between RyR1 and RyR2. Dantrolene also bound to the domain of the Leu 590 -Cys 609 region in RyR2 (12) . Dantrolene has no selectivity to RyR1 and RyR2 and therefore inhibits both RyR1 and RyR2. However, the data showing the increased expression of RyR2 in the NAcc of morphineconditioned mice and dosedependent suppression of morphineinduced pace preference by dantrolene suggest that RyR2 may play, at least in part, a key role in morphineinduced pace preference.
The mesolimbic dopaminergic projections from the VTA to the frontal cortex and nucleus accumbens play an important role in the rewarding effect of drugs of abuse including morphine (13) . In the present study, we found significant increases of RyR2 in the nucleus accumbens of the morphineconditioned mice, although morphineconditioning failed to modify RyR2 in the frontal cortex and VTA. These data indicate that morphineconditioning increases the expression of RyR2 in the nucleus accumbens. Our previous study has reported that dopamine D1 receptors show the regulatory potential on RyR2 expression in the develop ment of methamphetamine and cocaineinduced place preference (9, 10) , which suggests that RyR2 protein expression in the nucleus accumbens observed in the morphineconditioning may be mediated via dopamine D1receptor activation.
The conditioned place preference has been used exten sively as an animal model for investigating the rewarding effect of drugconditioned stimuli (13) . The development of druginduced conditioned place preference is associated with shortterm neuroadaptations induced by drug administration, which can cause subsequent wanting to use drugs of abuse. In the case of this study, the drug of abuse is morphine. The expression of druginduced conditioned place preference may be dependent on drug experience memory, which is retrieved when human and/or animals enter or are placed in the drugconditioned compartment in the postconditioning test. In the present study, intracerebroventricular administration of dantro lene during morphineconditioning significantly sup pressed the place preference produced by morphine. Such suppression of morphineinduced conditioned place preference by dantrolene administered during morphine conditioning may due to disturbance of CICR mediated via RyR suppression by dantrolene. On the other hand, dantrolene administered only immediately before postconditioning test, not during morphine conditioning, significantly inhibited morphineinduced place preference. These differences may be due to RyR2 upregulation when examining the effect of dantrolene on immediately before the postconditioning test. These data obtained by different protocols of dantrolene treat ment also suggest that upregulation of RyR2 in the nucleus accumbens may be a key player in not only the development of but also the expression of morphine induced place preference and that the changes in RyR2 function may be one of the essential events linking to neurochemical and behavioral adaptation in morphine induced place preference.
Nicotinemediated upregulation of RyR2 reinforces intracellular Ca 2+ signals and establishes a positive feed back loop that maintains upregulation of RyR2 (14) . A recent study has shown that dantrolene appears to modulate the alcoholinduced alcohol intake (15) and that ryanodine, a RyR antagonist, inhibits the develop ment of sensitization of nicotineinduced hyperlocomo tion (14) . We have previously reported that several drugs of abuse, such as cocaine and methamphetamine, induce functional correlation between changes of animal behaviors and intracellular Ca 2+ dynamics associated with expression of calcium channels such as Ltype high voltagegated calcium channels and RyRs (5, 9 -11). We therefore suppose that intracellular Ca 2+ dynamics involving RyR function may consist of, at least in part, a common molecular pathway for drug dependence of not only psychostimulants but morphine. Taken together these data, it is suggested that partial and/or full antago nists for RyRs with permeable capacity through the blood brain barrier may become possible therapeutic candidates to treat and/or prevent morphineinduced psychological dependence.
